COMMUNIQUÉS West-GlobeNewswire

Filing of Annual Report on Form 20-F
29/03/2019
Summit Therapeutics plc (‘Summit’ or the ‘Company’) Summit Therapeutics Files US Annual Report on Form 20-F Oxford, UK, and Cambridge, MA, US, 29 March 2019 – Summit Therapeutics plc (NASDAQ: SMMT, AIM: SUMM), a leader [...]
Auxly Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Outlook for 2019
29/03/2019
VANCOUVER, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Auxly Cannabis Group Inc. (TSX.V: XLY) (OTCQX: CBWTF) (" Auxly " or the " Company ") today released its fourth quarter and full year 2018 financial results [...]
Axovant Announces Clinical Updates from AXO-AAV-GM2 and AXO-Lenti-PD Studies
29/03/2019
-R&D Day featuring leading physicians and scientists in Parkinson’s disease, GM1 gangliosidosis and GM2 gangliosidosis (Tay-Sachs disease) will be webcast today at 8:30a.m. ET from New York- -Approximately 25% [...]
Emerald Health Therapeutics Delivers to Yukon and Adds Supply Agreements with Alberta and Saskatchewan
29/03/2019
VANCOUVER, British Columbia, March 29, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has fulfilled its first purchase order of cannabis from Yukon Liquor Corporation, [...]
ASLAN Pharmaceuticals Completes First Part of Single Ascending Dose Study for ASLAN004 Targeting Atopic Dermatitis
29/03/2019
Interim results support competitive efficacy, potential for monthly dosing and favourable safety profile SINGAPORE, March 29, 2019 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN, TPEx:6497), a clinical-stage [...]
Change in number of shares and votes in Saniona AB (publ)
29/03/2019
PRESS RELEASE March 29, 2019 During March, the registered number of shares and votes in Saniona AB (publ) (“Saniona”) has increased due to conversion of convertible notes issued pursuant to the convertible notes funding [...]
Health Canada grants Nexstim NBS system and NexSpeech® medical device license for Canada
29/03/2019
Company announcement, Helsinki, 29 March 2019 at 9.30 am (EET) Health Canada grants Nexstim NBS system and NexSpeech® medical device license for Canada Nexstim Plc (NXTMH:HEX, NXTMS:STO) (" Nexstim " or " Company "), [...]
Publication of Biohit Oyj Annual Report 2018
29/03/2019
Biohit Oyj Annual Financial Report March 29, 2018 at 9:30 am local time (EET) Biohit Oyj’s Annual Report 2018 is published today in PDF format. The annual report contains financial statements for 2018, the Report of the [...]
Notice of Biohit Oyj’s Annual General Meeting
29/03/2019
Notice of Biohit Oyj’s Annual General Meeting Biohit Oyj Stock Exchange Release March 29, 2019 at 9:30 am local time (EEST) Biohit Oyj shareholders are invited to attend the company’s Annual General Meeting to be held [...]
Laboratory set up in Berlin and strategic collaboration with leading German and Danish cancer coorporative groups entered to develop precision medicine for women’s cancers
29/03/2019
Press release Hoersholm, Denmark and Cambridge, MA, US, March 29, 2019 – Oncology Venture A/S (“OV” or “the Company”) , today announces a new important strategic collaboration to develop precision medicine for women’s [...]
Share capital and voting rights in Orphazyme A/S
29/03/2019
Orphazyme A/S Company announcement No. 11/2019 Company Registration No. 32266355 Copenhagen, March 29, 2019 – Following a share capital increase in Orphazyme A/S (ticker: ORPHA.CO), CVR no. 32266355 (“Orphazyme”) in [...]
Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in China
29/03/2019
LONDON, March 29, 2019 (GLOBE NEWSWIRE) -- Hutchison China MediTech Limited (“Chi-Med”) (AIM/Nasdaq: HCM) has initiated a registration-enabling Phase IIb/III study comparing surufatinib (HMPL-012 or sulfatinib) with [...]
IBA sélectionnée pour l’installation d’un centre de protonthérapie à cinq salles à Shenzhen, en Chine
29/03/2019
IBA sélectionnée pour l’installation d’un centre de protonthérapie à cinq salles à Shenzhen, en Chine Les négociations du contrat final débuteront dans les prochaines semaines Louvain-la-Neuve, Belgique, le 29 mars 2019 [...]
IBA Selected to Install Five-room Proton Therapy System in Shenzhen, China
29/03/2019
IBA Selected to Install Five-room Proton Therapy System in Shenzhen, China Final contract negotiations for the public tender will start in the coming weeks Louvain-la-Neuve, Belgium, 29 March, 2019 - IBA ( Ion Beam [...]
IBA VEND DEUX PREMIERS ACCÉLÉRATEURS RHODOTRON® À NORTHSTAR MEDICAL RADIOISOTOPES
29/03/2019
Le contrat signé porte sur huit machines Six autres machines seront livrées dans les prochaines années Louvain-la-Neuve, Belgique, le 29 mars 2019 - IBA (Ion Beam Applications S.A.), le premier fournisseur mondial de [...]
IBA SELLS FIRST TWO RHODOTRON® ACCELERATORS TO NORTHSTAR MEDICAL RADIOISOTOPES
29/03/2019
Total contract signed for eight systems Six others to be delivered over the coming years Louvain-La-Neuve, Belgium, March 29 th , 2019 - IBA (Ion Beam Applications S.A., EURONEXT), the world’s leading provider of proton [...]
Publication of ObsEva SA Invitation to 2019 Annual General Meeting of Shareholders
29/03/2019
Geneva, Switzerland and Boston, MA – March 29, 2019 - ObsEva SA (NASDAQ: OBSV / SIX: OBSN), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious [...]
Genkyotex Reverse Stock Split Takes Effect
29/03/2019
Completion of the 10-for-1 reverse stock split Technical change has no impact on value of shares held by shareholders GKTX ticker on Euronext remains unchanged ARCHAMPS, France, March 29, 2019 (GLOBE NEWSWIRE) -- [...]
Prise d’effet du regroupement d’actions de Genkyotex
29/03/2019
Finalisation du regroupement d’actions par 10 Cet ajustement technique est sans impact sur la valeur des titres Genkyotex détenus par les actionnaires Le code mnémonique reste inchangé (GKTX) ARCHAMPS, France, 29 mars [...]

Pages